88 related articles for article (PubMed ID: 23189555)
1. [IL-2-receptor associated action of the modified peptide fragments of human IL-2 on macrophages].
Onoprienko LV; Mikhaleva II; Voĭtenkov BO; Ivanov VT
Bioorg Khim; 2012; 38(4):413-20. PubMed ID: 23189555
[TBL] [Abstract][Full Text] [Related]
2. [Screening of short peptides binding to cell surface interleukin-2 receptor alpha chain].
Liu BY; Zhu P; Luo HB; Fu N
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul; 26(7):971-4. PubMed ID: 16864089
[TBL] [Abstract][Full Text] [Related]
3. Hot-spot mimicry of a cytokine receptor by a small molecule.
Thanos CD; DeLano WL; Wells JA
Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15422-7. PubMed ID: 17032757
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of interleukin-2/p55 receptor subunit interaction by complementary peptides.
Fassina G; Cassani G; Gnocchi P; Fornasiero MC; Isetta AM
Arch Biochem Biophys; 1995 Apr; 318(1):37-45. PubMed ID: 7726570
[TBL] [Abstract][Full Text] [Related]
5. Synthetic peptides as putative therapeutic agents in transplantation medicine: application of PEPSCAN to the identification of functional sequences in the extracellular domain of the interleukin-2 receptor beta chain (IL-2Rbeta).
Dionyssopoulou H; Mouzaki A; Slootstra J; Puijk W; Meloen R; Cordopatis P; Sotiropoulou G
J Immunol Methods; 2000 Jul; 241(1-2):83-95. PubMed ID: 10915851
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 2 (IL-2) variants engineered for increased IL-2 receptor alpha-subunit affinity exhibit increased potency arising from a cell surface ligand reservoir effect.
Rao BM; Driver I; Lauffenburger DA; Wittrup KD
Mol Pharmacol; 2004 Oct; 66(4):864-9. PubMed ID: 15385640
[TBL] [Abstract][Full Text] [Related]
7. Structural basis of immunosuppression by the therapeutic antibody daclizumab.
Yang H; Wang J; Du J; Zhong C; Zhang D; Guo H; Guo Y; Ding J
Cell Res; 2010 Dec; 20(12):1361-71. PubMed ID: 20820193
[TBL] [Abstract][Full Text] [Related]
8. Antiinflammatory properties of a peptide derived from interleukin-4.
Klementiev B; Enevoldsen MN; Li S; Carlsson R; Liu Y; Issazadeh-Navikas S; Bock E; Berezin V
Cytokine; 2013 Oct; 64(1):112-21. PubMed ID: 23972727
[TBL] [Abstract][Full Text] [Related]
9. Human IL-2Rɑ subunit binding modulation of IL-2 through a decline in electrostatic interactions: A computational and experimental approach.
Beig Parikhani A; Bagherzadeh K; Dehghan R; Biglari A; Shokrgozar MA; Riazi Rad F; Zeinali S; Talebkhan Y; Ajdary S; Ahangari Cohan R; Behdani M
PLoS One; 2022; 17(2):e0264353. PubMed ID: 35213635
[TBL] [Abstract][Full Text] [Related]
10. High-affinity CD25-binding IL-2 mutants potently stimulate persistent T cell growth.
Rao BM; Driver I; Lauffenburger DA; Wittrup KD
Biochemistry; 2005 Aug; 44(31):10696-701. PubMed ID: 16060678
[TBL] [Abstract][Full Text] [Related]
11. Cutting Edge: Differential Fine-Tuning of IL-2- and IL-15-Dependent Functions by Targeting Their Common IL-2/15Rβ/γc Receptor.
Meghnem D; Morisseau S; Frutoso M; Trillet K; Maillasson M; Barbieux I; Khaddage S; Leray I; Hildinger M; Quéméner A; Jacques Y; Mortier E
J Immunol; 2017 Jun; 198(12):4563-4568. PubMed ID: 28507024
[TBL] [Abstract][Full Text] [Related]
12. NMR characterization of interleukin-2 in complexes with the IL-2Ralpha receptor component, and with low molecular weight compounds that inhibit the IL-2/IL-Ralpha interaction.
Emerson SD; Palermo R; Liu CM; Tilley JW; Chen L; Danho W; Madison VS; Greeley DN; Ju G; Fry DC
Protein Sci; 2003 Apr; 12(4):811-22. PubMed ID: 12649439
[TBL] [Abstract][Full Text] [Related]
13. The c.305del3 in IL-2 gene in Homonoidea theoretically affects IL-2/IL-2Rα interaction as well as lymphocyte homeostasis.
Hosseinian H; Mahnam K; Shakhsi-Niaei M
Cytokine; 2018 Aug; 108():232-238. PubMed ID: 29246655
[TBL] [Abstract][Full Text] [Related]
14. Induction of interleukin-2 receptor alpha (IL-2Ralpha) expression by interleukin-2: important role of the interleukin-2 receptor beta chain region between the two Stat5 docking sites.
Imbert V; Rezzonico R; Reichenbach P; Nabholz M
Eur Cytokine Netw; 2002; 13(3):331-9. PubMed ID: 12231477
[TBL] [Abstract][Full Text] [Related]
15. Modification of C2 functional group on asiatic acid and the evaluation of hepatoprotective effects.
Jeong BS; Lee MK; Kim YC; Lee ES
Arch Pharm Res; 2007 Mar; 30(3):282-9. PubMed ID: 17424932
[TBL] [Abstract][Full Text] [Related]
16. Time-Dependent Regulation of IL-2R α-Chain (CD25) Expression by TCR Signal Strength and IL-2-Induced STAT5 Signaling in Activated Human Blood T Lymphocytes.
Shatrova AN; Mityushova EV; Vassilieva IO; Aksenov ND; Zenin VV; Nikolsky NN; Marakhova II
PLoS One; 2016; 11(12):e0167215. PubMed ID: 27936140
[TBL] [Abstract][Full Text] [Related]
17. The residues (35)proline and (41)cysteine of chicken IL-2 are critical for binding to chicken CD25.
Gu J; Xu J; Huang Z; Liao M; Zhou J
Dev Comp Immunol; 2010 Aug; 34(8):805-11. PubMed ID: 20230853
[TBL] [Abstract][Full Text] [Related]
18. [Immunomodulating properties of synthetic fragments of human interleukin-2].
Onoprienko LV; Mikhaleva II; Ivanova VT; Voĭtenkov BO; Okulov VB
Bioorg Khim; 1996 Mar; 22(3):180-90. PubMed ID: 8687510
[TBL] [Abstract][Full Text] [Related]
19. The search for inhibitors of interleukin-1 based on the sequence of interleukin-1 receptor antagonist.
Wieczorek Z; Kluczyk A; Slon-Usakiewicz JJ; Siemion IZ
Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(4):123-9. PubMed ID: 9575352
[TBL] [Abstract][Full Text] [Related]
20. The first alpha helix of interleukin (IL)-2 folds as a homotetramer, acts as an agonist of the IL-2 receptor beta chain, and induces lymphokine-activated killer cells.
Eckenberg R; Rose T; Moreau JL; Weil R; Gesbert F; Dubois S; Tello D; Bossus M; Gras H; Tartar A; Bertoglio J; Chouaïb S; Goldberg M; Jacques Y; Alzari PM; Thèze J
J Exp Med; 2000 Feb; 191(3):529-40. PubMed ID: 10662798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
